Crossmark

Early cardiotoxicity in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after HLA-haploidentical hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1007/s12185-025-03970-w

Published Online: 2025-03-23

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsukawa, Toshihiro https://orcid.org/0000-0003-2371-3778
Sugita, Junichi

Hashimoto, Daigo

Aiba, Masayuki

Okada, Kohei

Teshima, Takanori
License Information

Text and Data Mining valid from 2025-03-23

Version of Record valid from 2025-03-23
More Information

Article History

Received: 25 November 2024

Revised: 11 March 2025

Accepted: 11 March 2025

First Online: 23 March 2025

Declarations

:

: JS is currently serving as an editor of International Journal of Hematology. However, the editorial process for the current manuscript was independently handled by other editorial board members, and he did not influence the review process or editorial decision. TT is an adviser or consultant for Astellas, Kyowa Kirin, Novartis, and Bristol Myers Squibb; reports research support from Astellas, Luca-science, Otsuka, Priothera SAS, Pharma Essentia Japan, AbbVie, IQVIA Japan, Chugai, Kyowa Kirin, CMIC, Novartis, Bristol Myers Squibb, Janssen, and CSL Behring; reports grants from Asahi-Kasei, Eisai, Kyowa Kirin, Shionogi, Sumitomo-Pharma, Chugai.

Document is current

Any future updates will be listed below